David T Lubkin1, Muath Bishawi2, Andrew S Barbas2, Todd V Brennan3, Allan D Kirk2,4. 1. School of Medicine, Duke University, Durham, NC. 2. Department of Surgery, Duke University Medical Center, Durham, NC. 3. Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA. 4. Department of Immunology, Duke University Medical Center, Durham, NC.
Abstract
OBJECTIVES: Extracellular mitochondrial DNA and N-formyl peptides released following tissue damage may contribute to systemic inflammation through stimulation of the innate immune system. In this review, we evaluate existing in vivo human data regarding a role for mitochondrial DNA and N-formyl peptides in producing systemic inflammation in trauma and critical illness, investigate the utility of these molecules in risk prediction and clinical decision support, and provide suggestions for standardization of future research. DATA SOURCES: PubMed, Embase (1971-2017). STUDY SELECTION: Studies measuring extracellular mitochondrial DNA and/or N-formyl peptides in acutely ill patients. DATA EXTRACTION: Fifty-four studies were analyzed. Data extracted included article characteristics, methods, results, and performance in clinical prediction. DATA SYNTHESIS: The most common patient types investigated were trauma (19 studies) and sepsis (eight). In studies comparing patient mitochondrial DNA or N-formyl peptide levels to healthy controls, 38 (90.5%) reported significantly elevated mitochondrial DNA levels in patients at first reported time point, as did the one study making this comparison for N-formyl peptides. Nine studies (81.8%) reported significantly elevated plasma/serum mitochondrial DNA levels in at least one time point in patients who developed inflammatory complications of their primary pathology compared with patients without inflammatory complications. For the ability of mitochondrial DNA to predict complications or outcomes, the area under the curve was 0.7 or greater in 84.6% of receiver operating characteristic curves, and 92.9% of odds, adjusted odds, risk, and hazard ratios were statistically significant. CONCLUSIONS: Extracellular mitochondrial DNA levels are elevated early in patients' hospital courses in many acute illnesses and are higher in patients who develop inflammatory complications. Elevated mitochondrial DNA levels may be clinically useful in risk prediction and clinical decision support systems. Further research is needed to determine the role of extracellular N-formyl peptides in systemic inflammation and their possible clinical utility.
OBJECTIVES: Extracellular mitochondrial DNA and N-formyl peptides released following tissue damage may contribute to systemic inflammation through stimulation of the innate immune system. In this review, we evaluate existing in vivo human data regarding a role for mitochondrial DNA and N-formyl peptides in producing systemic inflammation in trauma and critical illness, investigate the utility of these molecules in risk prediction and clinical decision support, and provide suggestions for standardization of future research. DATA SOURCES: PubMed, Embase (1971-2017). STUDY SELECTION: Studies measuring extracellular mitochondrial DNA and/or N-formyl peptides in acutely ill patients. DATA EXTRACTION: Fifty-four studies were analyzed. Data extracted included article characteristics, methods, results, and performance in clinical prediction. DATA SYNTHESIS: The most common patient types investigated were trauma (19 studies) and sepsis (eight). In studies comparing patient mitochondrial DNA or N-formyl peptide levels to healthy controls, 38 (90.5%) reported significantly elevated mitochondrial DNA levels in patients at first reported time point, as did the one study making this comparison for N-formyl peptides. Nine studies (81.8%) reported significantly elevated plasma/serum mitochondrial DNA levels in at least one time point in patients who developed inflammatory complications of their primary pathology compared with patients without inflammatory complications. For the ability of mitochondrial DNA to predict complications or outcomes, the area under the curve was 0.7 or greater in 84.6% of receiver operating characteristic curves, and 92.9% of odds, adjusted odds, risk, and hazard ratios were statistically significant. CONCLUSIONS: Extracellular mitochondrial DNA levels are elevated early in patients' hospital courses in many acute illnesses and are higher in patients who develop inflammatory complications. Elevated mitochondrial DNA levels may be clinically useful in risk prediction and clinical decision support systems. Further research is needed to determine the role of extracellular N-formyl peptides in systemic inflammation and their possible clinical utility.
Authors: Liwen Lin; He Xu; Muath Bishawi; FeiFei Feng; Kannan Samy; George Truskey; Andrew S Barbas; Allan D Kirk; Todd V Brennan Journal: Am J Transplant Date: 2019-03-13 Impact factor: 8.086
Authors: Mark L Hepokoski; Mazen Odish; Michael T Lam; Nicole G Coufal; Mark L Rolfsen; Gerald S Shadel; Alexandra G Moyzis; Alva G Sainz; Puja G Takiar; Sagar Patel; Austin J Leonard; Negin Samandari; Emily Hansen; Samantha Trescott; Celina Nguyen; Kristen Jepsen; Gary Cutter; Mark N Gillespie; Roger G Spragg; Roman Sasik; Joachim H Ix Journal: Am J Physiol Lung Cell Mol Physiol Date: 2022-06-14 Impact factor: 6.011
Authors: Julie A Stortz; Russell B Hawkins; David C Holden; Steven L Raymond; Zhongkai Wang; Scott C Brakenridge; Joseph Cuschieri; Frederick A Moore; Ronald V Maier; Lyle L Moldawer; Philip A Efron Journal: Sci Rep Date: 2019-09-20 Impact factor: 4.379
Authors: Adam Chmielecki; Krzysztof Bortnik; Szymon Galczynski; Gianluca Padula; Hanna Jerczynska; Robert Stawski; Dariusz Nowak Journal: Biology (Basel) Date: 2022-01-10